Andrea Bonacchi

Andrea Bonacchi

Auto-generated profile, based on publicly available information

Andrea Bonacchi

Centro Studi e Ricerca Synthesis, Associazione di Promozione Sociale Sul Sentiero, Florence, Italy

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2006 in Gut
Verified
Journal Article
Closed access
PDF file
ENE Novo
E Novo
FMFabio Marra
Fabio Marra
EZE Zamara
E Zamara
LBL Valfrè di Bonzo
L Valfrè di Bonzo
LML Monitillo
L Monitillo
MPMaurizio Parola
Maurizio Parola
Background and aims: Myofibroblast-like cells, originating from activation of hepatic stellate cells (HSC/MFs), play a key role in liver fibrosis, a potentially reversible process that may rely on induction of HSC/MFs apoptosis. While this possibility has been shown in cultured rat HSC, very limited data are currently available for human HSC/MFs. Methods: Cultured human HSC/MFs were exposed to several proapoptotic stimuli, including those known to induce apoptosis in rat HSC/MFs, and induction of cell death and related mechanisms were investigated using morphology, molecular biology, and biochemical techniques. Results: In this study we report that fully activated human HSC/MFs did not undergo spontaneous apoptosis and survived to prolonged serum deprivation, Fas activation, or exposure to nerve growth factor, tumour necrosis factor α (TNF-α), oxidative stress mediators, doxorubicin, and etoposide. Induction of caspase dependent, mitochondria driven apoptosis in HSC/MFs was observed only when protein synthesis or transcription were inhibited. Importantly, the process of HSC activation was accompanied by changes in expression of a set of genes involved in apoptosis control. In particular, activated human HSC/MFs in culture overexpressed Bcl-2. The role of Bcl-2 was crucial as Bcl-2 silenced cells became susceptible to TNF-α induced apoptosis. Finally, Bcl-2 was markedly expressed in HSC/MFs present in liver tissue obtained from patients with hepatitis C virus related cirrhosis. Conclusions: Human activated HSC/MFs are resistant to most proapoptotic stimuli due to Bcl-2 overexpression and this feature may play a key role in the progression of fibrosis in chronic liver diseases.

8 April 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MRMaaike L. De Roo
Maaike L. De Roo
GMGuido Miccinesi
Guido Miccinesi
BOBregje D. Onwuteaka-Philipsen
Bregje D. Onwuteaka-Philipsen
NNNele Van Den Noortgate
Nele Van Den Noortgate
LBLieve Van Den Block
Lieve Van Den Block
OIOn Behalf Of Euro Impact
On Behalf Of Euro Impact
Dying at home and dying at the preferred place of death are advocated to be desirable outcomes of palliative care. More insight is needed in their usefulness as quality indicators. Our objective is to describe whether “the percentage of patients dying at home” and “the percentage of patients who died in their place of preference” are feasible and informative quality indicators. A mortality follow-back study was conducted, based on data recorded by representative GP networks regarding home-dwelling patients who died non-suddenly in Belgium (n = 1036), the Netherlands (n = 512), Italy (n = 1639) or Spain (n = 565). “The percentage of patients dying at home” ranged between 35.3% (Belgium) and 50.6% (the Netherlands) in the four countries, while “the percentage of patients dying at their preferred place of death” ranged between 67.8% (Italy) and 86.0% (Spain). Both indicators were strongly associated with palliative care provision by the GP (odds ratios of 1.55–13.23 and 2.30–6.63, respectively). The quality indicator concerning the preferred place of death offers a broader view than the indicator concerning home deaths, as it takes into account all preferences met in all locations. However, GPs did not know the preferences for place of death in 39.6% (the Netherlands) to 70.3% (Italy), whereas the actual place of death was known in almost all cases. GPs know their patients’ actual place of death, making the percentage of home deaths a feasible indicator for collection by GPs. However, patients’ preferred place of death was often unknown to the GP. We therefore recommend using information from relatives as long as information from GPs on the preferred place of death is lacking. Timely communication about the place where patients want to be cared for at the end of life remains a challenge for GPs.

1 July 2002 in Journal of Hepatology
Verified
Journal Article
Closed access
EEEva Efsen
Eva Efsen
CGCecilia Grappone
Cecilia Grappone
RDRaffaella M.S DeFranco
Raffaella M.S DeFranco
SMStefano Milani
Stefano Milani
RRRoberto G Romanelli
Roberto G Romanelli
FMFabio Marra
Fabio Marra

9 April 2013 in Journal of Personality Assessment
Verified
Journal Article
Closed access
FCFRANCESCA CHIESI
FRANCESCA CHIESI
SGSilvia Galli
Silvia Galli
CPCaterina Primi
Caterina Primi
PBPaolo Innocenti Borgi
Paolo Innocenti Borgi
ABAndrea Bonacchi
Andrea Bonacchi
The accuracy of the Life Orientation Test–Revised (LOT–R) in measuring dispositional optimism was investigated applying item response theory (IRT). The study was conducted on a sample of 484 university students (62% males, M age = 22.79 years, SD = 5.63). After testing the 1-factor structure of the scale, IRT was applied to evaluate the functioning of the LOT–R along the pessimism–optimism continuum. Item parameter estimates and the test information function showed that each item and the global scale satisfactorily measured the latent trait. Referring to the IRT estimated trait levels, the validity of the LOT–R was studied examining the relationships between dispositional optimism and psychological well-being, sense of mastery, and sense of coherence. Overall findings based on IRT analyses provide evidence of the accuracy of the LOT–R and suggest possible modifications of the scale to improve the assessment of dispositional optimism.

1 March 2001 in Hepatology
Verified
Journal Article
Open access
PDF file
EEEva Efsen
Eva Efsen
ABAndrea Bonacchi
Andrea Bonacchi
SPSabrina Pastacaldi
Sabrina Pastacaldi
AVAnthony J. Valente
Anthony J. Valente
UWUlrich O. Wenzel
Ulrich O. Wenzel
FMFabio Marra
Fabio Marra
Activated hepatic stellate cells (HSC) regulate the liver “wound‐healing” response through expression of chemokines, including monocyte chemoattractant protein‐1 (MCP‐1), which participate in the formation of the inflammatory infiltrate during liver injury. Cyclooxygenase (COX) catalyzes the conversion of arachidonic acid into prostaglandins, which may contribute to the inflammatory response. In this study, we investigated the effects of COX inhibitors on the expression of MCP‐1 in cultured HSC. Pretreatment of HSC with nonspecific COX inhibitors such as indomethacin or ibuprofen markedly reduced the expression of MCP‐1 caused by exposure to tumor necrosis factor α (TNF‐α) or interleukin‐1α (IL‐1α). NS‐398, a specific COX‐2 inhibitor, also resulted in a dose‐dependent inhibition of MCP‐1 gene and protein expression. These effects were dependent on reduced MCP‐1 transcription, as established using a reporter plasmid. In contrast, the up‐regulation of MCP‐1 expression caused by interferon gamma (IFN‐γ) was not sensitive to COX inhibitors. Quiescent HSC did not show detectable expression of COX‐2, which became evident after activation in culture, and while TNF‐α and IL‐1α markedly increased the expression of COX‐2, IFN‐γ did not have any effects. Pretreatment of HSC with the stable cyclic adenosine monophosphate (cAMP) analog, 8‐bromo cAMP, reverted the effects of the COX‐2 inhibitor, but not of a nuclear factor‐κB (NF‐κB) inhibitor, demonstrating that prostaglandins modulate MCP‐1 expression via production of cAMP. On the other hand, the action of NF‐κB inhibitors was negligible in IFN‐γ—stimulated cells. These findings indicate that cross‐talk between cytokines and a prostaglandin‐cAMP pathway differentially regulates the proinflammatory potential of HSC, contributing to the modulation of liver tissue inflammation.

1 July 2004 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
PDF file
FMFabio Marra
Fabio Marra
WDWanda Delogu
Wanda Delogu
IPIlaria Petrai
Ilaria Petrai
SPSabrina Pastacaldi
Sabrina Pastacaldi
ABAndrea Bonacchi
Andrea Bonacchi
PGPaolo Gentilini
Paolo Gentilini
Hepatic stellate cells (HSC) coordinate the liver wound-healing response through secretion of several cytokines and chemokines, including CCL2 (formerly known as monocyte chemoattractant protein-1). In this study, we evaluated the role of different proteins of the MAPK family (ERK, p38MAPK, and JNK) in the regulation of CCL2 expression by HSC, as an index of their proinflammatory activity. Several mediators activated all three MAPK, including TNF, IL-1, and PDGF. To assess the relative role of the different MAPKs, specific pharmacological inhibitors were used; namely, SB203580 (p38MAPK), SP600125 (JNK), and PD98059 (MEK/ERK). The efficacy and specificity of the different inhibitors in our cellular system were verified analyzing the enzymatic activity of the different MAPKs using in vitro kinase assays and/or testing the inhibition of phosphorylation of downstream substrates. SB203580 and SP600125 dose-dependently inhibited CCL2 secretion and gene expression induced by IL-1 or TNF. In contrast, inhibition of ERK did not affect the upregulation of CCL2 induced by the two cytokines. Finally, activin A was also found to stimulate CCL2 expression and to activate ERK, JNK, p38, and their downstream targets. Unlike in cells exposed to proinflammatory cytokines, all three MAPKs were required to induce CCL2 secretion in response to activin. We conclude that members of the MAPK family differentially regulate cytokine-induced chemokine expression in human HSC.